| 000 | 01595 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517181545.0 | ||
| 264 | 0 | _c20180626 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a2051-1426 | ||
| 024 | 7 |
_a10.1186/s40425-017-0287-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJeyakumar, Ghayathri | |
| 245 | 0 | 0 |
_aNeutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy. _h[electronic resource] |
| 260 |
_bJournal for immunotherapy of cancer _c10 2017 |
||
| 300 |
_a82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xblood |
| 650 | 0 | 4 |
_aLymphocytes _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutrophils _xmetabolism |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKim, Seongho | |
| 700 | 1 | _aBumma, Naresh | |
| 700 | 1 | _aLandry, Craig | |
| 700 | 1 | _aSilski, Cynthia | |
| 700 | 1 | _aSuisham, Stacey | |
| 700 | 1 | _aDickow, Brenda | |
| 700 | 1 | _aHeath, Elisabeth | |
| 700 | 1 | _aFontana, Joseph | |
| 700 | 1 | _aVaishampayan, Ulka | |
| 773 | 0 |
_tJournal for immunotherapy of cancer _gvol. 5 _gno. 1 _gp. 82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s40425-017-0287-5 _zAvailable from publisher's website |
| 999 |
_c27694574 _d27694574 |
||